Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA
Purpose: the main purpose of this article was to study the modern tools of the public innovation policy in the global pharmaceutical industry (US and EU cases), which is one of the most knowledge-intensive sectors of the global economy. During the study, it was necessary to achieve the following obj...
Saved in:
| Main Author: | Z. A. Mamedyarov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Nauka
2017-04-01
|
| Series: | Модернизация, инновация, развитие |
| Subjects: | |
| Online Access: | https://www.mir-nayka.com/jour/article/view/725 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique
by: Philippe Abecassis, et al.
Published: (2015-06-01) -
Towards a smart factory in the pharmaceutical industry
by: Majstorović Vidosav D.
Published: (2025-01-01) -
An assessment of Information disclosures by Pharmaceutical Industry: Evidence from India
by: Rupali Khanna, et al.
Published: (2019-10-01) -
Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?
by: Marie-Hélène Bacon
Published: (2009-11-01) -
Alternative strategies for investing in corporate R&D (on the example of the global pharmaceutical industry)
by: О. A. Yeremchenko
Published: (2018-12-01)